Clinical Trials Logo

Anxiety Disorder Generalized clinical trials

View clinical trials related to Anxiety Disorder Generalized.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04524975 Completed - Clinical trials for Anxiety Disorder Generalized

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Start date: October 2, 2018
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled, dose-finding pilot study to assess the efficacy and safety of CD-008-0045 in patients with Generalized Anxiety Disorder (GAD). Each patient will participate in the study for the period of approximately 10 weeks: Screening and Run-in period: 1 week; Study Treatment period: 8 weeks; Follow-up period: 1 week.